FDA Expands Vemlidy Use to Adolescents With Chronic HBV

  • 📰 Medscape
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 55%

United States Headlines News

United States Latest News,United States Headlines

✅ FDAapproves tenofovir alafenamide for the treatment of chronic HBV infection with compensated liver disease in children aged 12 years and older. MedTwitter

The US Food and Drug Administration has expanded the indication for tenofovir alafenamide to children aged 12 years and older with chronicThe approval in the pediatric patient population was supported by 24-week data from a phase 2 clinical trial comparing treatment with tenofovir alafenamide with placebo in 70 treatment-naïve and treatment-experienced patients aged 12 to < 18 years weighing at least 35 kg.

The study met its primary endpoint of percentage of patients with HBV DNA levels < 20 IU/mL at 24 weeks of therapy, Gilead said in aOverall, 10 of 47 patients treated with tenofovir alafenamide achieved HBV DNA < 20 IU/mL at 24 weeks compared with none of 23 treated with placebo. The rates of serum alanine aminotransferase normalization were higher with tenofovir alafenamide than with placebo .

The mean percent changes in bone mineral density from baseline to 24 weeks were numerically similar for tenofovir alafenamide- and placebo-treated patients . The mean changes from baseline BMD Z-scores were -0.03 and -0.09 for lumbar spine, and -0.05 and -0.01 for whole body, for tenofovir alafenamide and placebo groups, respectively.

Source: Law Daily Report (lawdailyreport.net)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA recommends against using infant head shaping pillows, calls them 'unsafe'ATTENTION PARENTS: Officials are urging parents of newborns to stop using popular infant head-shaping pillows, calling them 'unsafe' -
Source: News12 - 🏆 591. / 51 Read more »

USPSTF Doesn't Change Postmenopausal Hormone RecommendationsUSPSTF's recommendations for the use of hormone therapy in postmenopausal women remains the same: Do not use hormone therapy for preventing chronic conditions, such as CV disease, cancer, and osteoporosis, or bone fracture. MedTwitter
Source: Medscape - 🏆 386. / 55 Read more »

FDA Reports Shortage of Commonly Used AntibioticsThe department also listed a shortage for an oral powder. Amoxicillin is available in chewable tablets or capsules. You can buy that stuff off the shelf in Mexico and Thailand. Only in America are you forced to enroll in an overpriced healthcare system just to get a prescription. Amox is crap anyways; give me the good stuff; Augmenting or Zithromax!
Source: NBCDFW - 🏆 288. / 63 Read more »

Christina Applegate: 'I wish I had paid attention' amid worsening symptoms of multiple sclerosisActress Christina Applegate was diagnosed with the chronic autoimmune disease in 2021. ms multiplesclerosis alabamanewsnetwork
Source: ALNewsNetwork - 🏆 583. / 51 Read more »

Exclusive: 1Password acquiring ID authentication startup PassageThe deal allows 1Password to expand beyond phrase-based password managers. 🥳 Sweet. Can this be used to screen for legal voting? VoterID This is really going to send shockwaves through the password enthusiast space.
Source: axios - 🏆 302. / 63 Read more »